How important is donor age in liver transplantation?

World Journal of Gastroenterology

Volumn 22, Issue 21, 2016, Pages 4966-4976

  Lué, Alberto ^a,b   Solanas, Estela ^b   Baptista, Pedro ^c   Lorente, Sara ^a,b   Araiz, Juan J ^a   Garcia Gil, Agustin ^a,b   Serrano, M Trinidad ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Aging; Graft survival; Liver regeneration; Liver transplantation; Old donor

Indexed keywords

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; AGING; ASSESSMENT OF HUMANS; BALANCE OF RISK SCORE; BILIARY TRACT DISEASE; CHILD; CONTROLLED STUDY; DECEASED DONOR; DONOR; DONOR AGE; DONOR RISK INDEX; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LIVER FUNCTION; LIVER GRAFT; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; PRESCHOOL CHILD; PROGNOSIS; REINFECTION; REVIEW; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL OUTCOMES FOLLOWING LIVER TRANSPLANTATION SCORE; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT; ADVERSE EFFECTS; CAUSE OF DEATH; DECISION SUPPORT SYSTEM; DONOR SELECTION; INFANT; MORTALITY; NEWBORN; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PROCEDURES; SUPPLY AND DISTRIBUTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; DONOR SELECTION; GRAFT SURVIVAL; HUMANS; INFANT; INFANT, NEWBORN; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84978858671     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i21.4966     Document Type: Review

References (67)

1. Adam R, Karam V, Delvart V, O'Grady J, Mirza D, Klempnauer J, Castaing D, Neuhaus P, Jamieson N, Salizzoni M, Pollard S, Lerut J, Paul A, Garcia-Valdecasas JC, Rodríguez FS, Burroughs A. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012; 57: 675-688 [PMID: 22609307 DOI: 10.1016/j.jhep.2012.04.015]
2. Adam R, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, Neuhaus P, Lerut J, Salizzoni M, Pollard S, Muhlbacher F, Rogiers X, Garcia Valdecasas JC, Berenguer J, Jaeck D, Moreno Gonzalez E. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 1231-1243 [PMID: 14625822 DOI: 10.1016/j.lts.2003.09.018]
3. Cuervas-Mons V, de la Rosa G, Pardo F, San Juan F, Valdivieso A. [Activity and results of liver transplantation in Spain during 1984-2012. Analysis of the Spanish Liver Transplant Registry]. Med Clin (Barc) 2015; 144: 337-347 [PMID: 25458515 DOI: 10.1016/j.medcli.2014.07.036]
4. Emre S, Schwartz ME, Altaca G, Sethi P, Fiel MI, Guy SR, Kelly DM, Sebastian A, Fisher A, Eickmeyer D, Sheiner PA, Miller CM. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996; 62: 62-65 [PMID: 8693547 DOI: 10.1097/0 0007890-199607150-00013]
5. Rodríguez González F, Jiménez Romero C, Rodríguez Romano D, Loinaz Segurola C, Marqués Medina E, Pérez Saborido B, García García I, Rodríguez Cañete A, Moreno González E. Orthotopic liver transplantation with 100 hepatic allografts from donors over 60 years old. Transplant Proc 2002; 34: 233-234 [PMID: 11959260 DOI: 10.1016/S0041-1345(01)02738-5]
6. Adam R, Cailliez V, Majno P, Karam V, McMaster P, Caine RY, O' Grady J, Pichlmayr R, Neuhaus P, Otte JB, Hoeckerstedt K, Bismuth H. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000; 356: 621-627 [PMID: 10968434 DOI: 10.1016/S0140-6736(00)02603-9]
7. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, O'Grady JG, Castaing D, Klempnauer J, Jamieson N, Neuhaus P, Lerut J, de Ville de Goyet J, Pollard S, Salizzoni M, Rogiers X, Muhlbacher F, Garcia Valdecasas JC, Broelsch C, Jaeck D, Berenguer J, Gonzalez EM, Adam R. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006; 367: 225-232 [PMID: 16427491 DOI: 10.1016/S0140-6736(06)68033-1]
8. Berenguer M, Prieto M, San Juan F, Rayón JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in patient survival among HCVinfected liver transplant recipients. Hepatology 2002; 36: 202-210 [PMID: 12085366 DOI: 10.1053/jhep.2002.33993]
9. Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004; 77: 84-92 [PMID: 14724440 DOI: 10.1097/01.TP.0000095896.07048.BB]
10. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790 [PMID: 16539636 DOI: 10.1111/j.1600-6143.2006.01242.x]
11. Reese PP, Sonawane SB, Thomasson A, Yeh H, Markmann JF. Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival. Transplantation 2008; 85: 1737-1744 [PMID: 18580465 DOI: 10.1097/TP.0b013e3181722f75]
12. Serrano MT, Garcia-Gil A, Arenas J, Ber Y, Cortes L, Valiente C, Araiz JJ. Outcome of liver transplantation using donors older than 60 years of age. Clin Transplant 2010; 24: 543-549 [PMID: 19925474 DOI: 10.1111/j.1399-0012.2009.01135.x]
13. Anderson CD, Vachharajani N, Doyle M, Lowell JA, Wellen JR, Shenoy S, Lisker-Melman M, Korenblat K, Crippin J, Chapman WC. Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg 2008; 207: 847-852 [PMID: 19183530 DOI: 10.1016/j.jamcollsurg.2008.08.0 09]
14. Alamo JM, Olivares C, Jiménez G, Bernal C, Marín LM, Tinoco J, Suárez G, Serrano J, Padillo J, Gómez MÁ. Donor characteristics that are associated with survival in liver transplant recipients older than 70 years with grafts. Transplant Proc 2013; 45: 3633-3636 [PMID: 24314980 DOI: 10.1016/j.transproceed.2013.10.031]
15. Kim DY, Moon J, Island ER, Tekin A, Ganz S, Levi D, Selvaggi G, Nishida S, Tzakis AG. Liver transplantation using elderly donors: a risk factor analysis. Clin Transplant 2011; 25: 270-276 [PMID: 20184629 DOI: 10.1111/j.1399-0012.2010.01222.x]
16. Han JH, You YK, Na GH, Kim EY, Lee SH, Hong TH, Kim DG. Outcomes of living donor liver transplantation using elderly donors. Ann Surg Treat Res 2014; 86: 184-191 [PMID: 24783177 DOI: 10.4174/astr.2014.86.4.184]
17. Dayangac M, Taner CB, Yaprak O, Demirbas T, Balci D, Duran C, Yuzer Y, Tokat Y. Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl 2011; 17: 548-555 [PMID: 21506243 DOI: 10.1002/lt.22276]
18. Ikegami T, Nishizaki T, Yanaga K, Shimada M, Kishikawa K, Nomoto K, Uchiyama H, Sugimachi K. The impact of donor age on living donor liver transplantation. Transplantation 2000; 70: 1703-1707 [PMID: 11152100 DOI: 10.1097/00007890-200012270-00007]
19. Ikegami T, Taketomi A, Ohta R, Soejima Y, Yoshizumi T, Shimada M, Maehara Y. Donor age in living donor liver transplantation. Transplant Proc 2008; 40: 1471-1475 [PMID: 18589131 DOI: 10.1016/j.transproceed.2008.02.084]
20. Iwamoto T, Yagi T, Umeda Y, Sato D, Matsukawa H, Matsuda H, Shinoura S, Sadamori H, Mizuno K, Yoshida R, Tanaka N. The impact of donor age on the outcome of adult living donor liver transplantation. Transplantation 2008; 85: 1240-1245 [PMID: 18475178 DOI: 10.1097/TP.0b013e31816c7e90]
21. Ono Y, Kawachi S, Hayashida T, Wakui M, Tanabe M, Itano O, Obara H, Shinoda M, Hibi T, Oshima G, Tani N, Mihara K, Kitagawa Y. The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery 2011; 150: 154-161 [PMID: 21719061 DOI: 10.1016/j.surg.2011.05.004]
22. Uchiyama H, Shirabe K, Kimura K, Yoshizumi T, Ikegami T, Harimoto N, Maehara Y. Outcomes of adult-to-adult living donor liver transplantation in 321 recipients. Liver Transpl 2016; 22: 305-315 [PMID: 26610068 DOI: 10.1002/lt.24378]
23. Li C, Wen TF, Yan LN, Li B, Yang JY, Xu MQ, Wang WT, Wei YG. Safety of living donor liver transplantation using older donors. J Surg Res 2012; 178: 982-987 [PMID: 22835951 DOI: 10.1016/j.jss.2012.06.065]
24. Wang K, Jiang WT, Deng YL, Pan C, Shen ZY. Effect of donor age on graft function and long-term survival of recipients undergoing living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2015; 14: 50-55 [PMID: 25655290 DOI: 10.1016/S1499-3872(15)60334-4]
25. Braat AE, Blok JJ, Putter H, Adam R, Burroughs AK, Rahmel AO, Porte RJ, Rogiers X, Ringers J; European Liver and Intestine Transplant Association (ELITA) and Eurotransplant Liver Intestine Advisory Committee (ELIAC). The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant 2012; 12: 2789-2796 [PMID: 22823098 DOI: 10.1111/j.1600-6143.2012.04195 x]
26. Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Guarrera JV, Brown RS, Emond JC. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008; 8: 2537-2546 [PMID: 18945283 DOI: 10.1111/j.1600-6143.2008.02400.x]
27. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009; 9: 318-326 [PMID: 19120079 DOI: 10.1111/j.1600-6143.2008.02491. x]
28. Dutkowski P, Oberkofler CE, Slankamenac K, Puhan MA, Schadde E, Müllhaupt B, Geier A, Clavien PA. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg 2011; 254: 745-753; discussion 753 [PMID: 22042468 DOI: 10.1097/SLA.0b013e3182365081]
29. Thorsen T, Aandahl EM, Bennet W, Olausson M, Ericzon BG, Nowak G, Duraj F, Isoniemi H, Rasmussen A, Karlsen TH, Foss A. Transplantation With Livers From Deceased Donors Older Than 75 Years. Transplantation 2015; 99: 2534-2542 [PMID: 25909464 DOI: 10.1097/TP.0000000000000728]
30. Verdonk RC, Buis CI, Porte RJ, van der Jagt EJ, Limburg AJ, van den Berg AP, Slooff MJ, Peeters PM, de Jong KP, Kleibeuker JH, Haagsma EB. Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl 2006; 12: 726-735 [PMID: 16628689 DOI: 10.1002/lt.20714]
31. Sundaram V, Jones DT, Shah NH, de Vera ME, Fontes P, Marsh JW, Humar A, Ahmad J. Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era. Liver Transpl 2011; 17: 428-435 [PMID: 21445926 DOI: 10.1002/lt.22251]
32. Lüthold SC, Kaseje N, Jannot AS, Mentha G, Majno P, Toso C, Belli DC, McLin VA, Wildhaber BE. Risk factors for early and late biliary complications in pediatric liver transplantation. Pediatr Transplant 2014; 18: 822-830 [PMID: 25263826 DOI: 10.1111/petr.12363]
33. Heidenhain C, Pratschke J, Puhl G, Neumann U, Pascher A, Veltzke-Schlieker W, Neuhaus P. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int 2010; 23: 14-22 [PMID: 19691661 DOI: 10.1111/j.1432-2277.2009.00947.x]
34. Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 2003; 75: 1659-1663 [PMID: 12777852 DOI: 10.1097/01. TP.0000071487.73903.90]
35. Cutrin JC, Cantino D, Biasi F, Chiarpotto E, Salizzoni M, Andorno E, Massano G, Lanfranco G, Rizzetto M, Boveris A, Poli G. Reperfusion damage to the bile canaliculi in transplanted human liver. Hepatology 1996; 24: 1053-1057 [PMID: 8903374 DOI: 10.1002/hep.510240512]
36. Noack K, Bronk SF, Kato A, Gores GJ. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation 1993; 56: 495-500 [PMID: 8212138 DOI: 10.1097 /00007890-199309000-00001]
37. Ghinolfi D, De Simone P, Lai Q, Pezzati D, Coletti L, Balzano E, Arenga G, Carrai P, Grande G, Pollina L, Campani D, Biancofiore G, Filipponi F. Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors. Liver Transpl 2016; 22: 588-598 [PMID: 26784011 DOI: 10.1002/lt.24401]
38. Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005; 5: 549-557 [PMID: 15707410 DOI: 10.1111/j.1600-6143.2005.00741.x]
39. Ghinolfi D, Marti J, De Simone P, Lai Q, Pezzati D, Coletti L, Tartaglia D, Catalano G, Tincani G, Carrai P, Campani D, Miccoli M, Biancofiore G, Filipponi F. Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transplant 2014; 14: 2062-2071 [PMID: 25307037 DOI: 10.1111/ajt.12843]
40. Dumortier J, Salamé E, Roche B, Hurtova M, Conti F, Radenne S, Vanlemmens C, Pageaux GP, Saliba F, Samuel D, Compagnon P, Neau-Cransac M, Calmus Y, Guillaud O, Gugenheim J, Altieri M, Durand F, Hardwigsen J, Lorho R, Dharancy S, Leroy V, Di Giambattista F, Duvoux C. Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study). Clin Res Hepatol Gastroenterol 2014; 38: 292-299 [PMID: 24685602 DOI: 10.1016/j.clinre.2014.02.007]
41. Berenguer M, Crippin J, Gish R, Bass N, Bostrom A, Netto G, Alonzo J, Garcia-Kennedy R, Rayón JM, Wright TL. A model to predict severe HCV-related disease following liver transplantation. Hepatology 2003; 38: 34-41 [PMID: 12829984 DOI: 10.1053/jhep.2003.50278]
42. Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, Garcia-Valdecasas JC, Salizzoni M, Moreno GE, Mirza D. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006; 81: 7-14 [PMID: 16421468 DOI: 10.1097/01.tp.0000188619.30677.84]
43. Berenguer M, Charco R, Manuel Pascasio J, Ignacio Herrero J. Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation. Liver Int 2012; 32: 712-731 [PMID: 22221843 DOI: 10.1111/j.1478-3231.2011.02731.x]
44. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248-252 [PMID: 12117889 DOI: 10.1136/gut.51.2.248]
45. Selzner N, Renner EL, Selzner M, Adeyi O, Kashfi A, Therapondos G, Girgrah N, Herath C, Levy GA, Lilly L. Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. Transplantation 2009; 88: 1214-1221 [PMID: 19935376 DOI: 10.1097/TP.0b013e3181bd783c]
46. Berenguer M, Aguilera V, Prieto M, Ortiz C, Rodríguez M, Gentili F, Risalde B, Rubin A, Cañada R, Palau A, Rayón JM. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis. Liver Transpl 2009; 15: 738-746 [PMID: 19562707 DOI: 10.1002/lt.21707]
47. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol 2016; 64: 433-485 [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006]
48. Fontana RJ, Brown RS, Moreno-Zamora A, Prieto M, Joshi S, Londoño MC, Herzer K, Chacko KR, Stauber RE, Knop V, Jafri SM, Castells L, Ferenci P, Torti C, Durand CM, Loiacono L, Lionetti R, Bahirwani R, Weiland O, Mubarak A, ElSharkawy AM, Stadler B, Montalbano M, Berg C, Pellicelli AM, Stenmark S, Vekeman F, Ionescu-Ittu R, Emond B, Reddy KR. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection. Liver Transpl 2016; 22: 446-458 [PMID: 26890629 DOI: 10.1002/lt.24416]
49. Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology 2015; 148: 100-107.e1 [PMID: 25261839 DOI: 10.1053/j.gastro.2014.09.023]
50. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301 [PMID: 2643548 DOI: 10.1002/hep.1840090222]
51. Marchesini G, Bua V, Brunori A, Bianchi G, Pisi P, Fabbri A, Zoli M, Pisi E. Galactose elimination capacity and liver volume in aging man. Hepatology 1988; 8: 1079-1083 [PMID: 3417228 DOI: 10.1002/hep.1840080516]
52. Schmucker DL. Hepatocyte fine structure during maturation and senescence. J Electron Microsc Tech 1990; 14: 106-125 [PMID: 2406386 DOI: 10.1002/jemt.1060140205]
53. Schmucker DL, Sanchez H. Liver regeneration and aging: a current perspective. Curr Gerontol Geriatr Res 2011; 2011: 526379 [PMID: 21912543 DOI: 10.1155/2011/526379]
54. Enkhbold C, Morine Y, Utsunomiya T, Imura S, Ikemoto T, Arakawa Y, Saito Y, Yamada S, Ishikawa D, Shimada M. Dysfunction of liver regeneration in aged liver after partial hepatectomy. J Gastroenterol Hepatol 2015; 30: 1217-1224 [PMID: 25682855 DOI: 10.1111/jgh.12930]
55. Takubo K, Nakamura K, Izumiyama N, Furugori E, Sawabe M, Arai T, Esaki Y, Mafune K, Kammori M, Fujiwara M, Kato M, Oshimura M, Sasajima K. Telomere shortening with aging in human liver. J Gerontol A Biol Sci Med Sci 2000; 55: B533-B536 [PMID: 11078086 DOI: 10.1093/gerona/55.11.B533]
56. Aikata H, Takaishi H, Kawakami Y, Takahashi S, Kitamoto M, Nakanishi T, Nakamura Y, Shimamoto F, Kajiyama G, Ide T. Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res 2000; 256: 578-582 [PMID: 10772830 DOI: 10.1006/excr.2000.4862]
57. Aini W, Miyagawa-Hayashino A, Tsuruyama T, Hashimoto S, Sumiyoshi S, Ozeki M, Tamaki K, Uemoto S, Haga H. Telomere shortening and karyotypic alterations in hepatocytes in long-term transplanted human liver allografts. Transpl Int 2012; 25: 956-966 [PMID: 22775391 DOI: 10.1111/j.1432-2277.2012.01523.x]
58. de Grey A. Response to "telomere shortening with aging in human liver". J Gerontol A Biol Sci Med Sci 2001; 56: B237-B238 [PMID: 11407362 DOI: 10.1093/gerona/56.6.B237]
59. Lazzerini Denchi E, Celli G, de Lange T. Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication. Genes Dev 2006; 20: 2648-2653 [PMID: 17015429 DOI: 10.1101/gad.1453606]
60. Timchenko NA. Aging and liver regeneration. Trends Endocrinol Metab 2009; 20: 171-176 [PMID: 19359195 DOI: 10.1016/j.tem.2009.01.005]
61. Wang GL, Shi X, Salisbury E, Sun Y, Albrecht JH, Smith RG, Timchenko NA. Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex. J Biol Chem 2007; 282: 1468-1478 [PMID: 17107955 DOI: 10.1074/jbc.M608226200]
62. Furrer K, Rickenbacher A, Tian Y, Jochum W, Bittermann AG, Käch A, Humar B, Graf R, Moritz W, Clavien PA. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc Natl Acad Sci USA 2011; 108: 2945-2950 [PMID: 21282654 DOI: 10.1073/pnas.1012531108]
63. Serrano T, Mitry RR, Terry C, Lehec SC, Dhawan A, Hughes RD. The effects of immunosuppressive agents on the function of human hepatocytes in vitro. Cell Transplant 2006; 15: 777-783 [PMID: 17269448 DOI: 10.3727/000000006783981530]
64. Yousef H, Conboy MJ, Morgenthaler A, Schlesinger C, Bugaj L, Paliwal P, Greer C, Conboy IM, Schaffer D. Systemic attenuation of the TGF-β pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal. Oncotarget 2015; 6: 11959-11978 [PMID: 26003168 DOI: 10.18632/oncotarget.3851]
65. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005; 433: 760-764 [PMID: 15716955 DOI: 10.1038/nature03260]
66. Wang MJ, Chen F, Li JX, Liu CC, Zhang HB, Xia Y, Yu B, You P, Xiang D, Lu L, Yao H, Borjigin U, Yang GS, Wangensteen KJ, He ZY, Wang X, Hu YP. Reversal of hepatocyte senescence after continuous in vivo cell proliferation. Hepatology 2014; 60: 349-361 [PMID: 24711261 DOI: 10.1002/hep.27094]
67. Hodgson R, Christophi C. What determines ageing of the transplanted liver? HPB (Oxford) 2015; 17: 222-225 [PMID: 25263287 DOI: 10.1111/hpb.12339]